(Q44516860)

3 December 2017

Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case report (English)

1 reference

3 December 2017

capillary leak syndrome

1 reference

1 reference

V Kataja

2

0 references

author name string

K Pulkkanen

series ordinal

1

1 reference

PubMed ID

12868557

3 December 2017

R Johansson

series ordinal

3

1 reference

PubMed ID

12868557

3 December 2017

language of work or name

1 reference

1 June 2003

1 reference

3 December 2017

Journal of Chemotherapy

1 reference

3 December 2017

15

1 reference

3 December 2017

3

1 reference

3 December 2017

287-289

1 reference

Fatal pulmonary toxicity resulting from treatment with gemcitabine

3 December 2017

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.287

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.287

Phase II study of gemcitabine in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.287

Advanced breast cancer: a phase II trial with gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.287

Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.287

Gemcitabine-induced systemic capillary leak syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.287

Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.287

Initial evidence of endothelial cell apoptosis as a mechanism of systemic capillary leak syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.287

Overview of interleukin-2 as an immunotherapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.287

Evaluation of noninvasive determinants for capillary leakage syndrome in septic shock patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.287

Activity of Gemcitabine in Patients with Advanced Ovarian Cancer: Responses Seen Following Platinum and Paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.3.287

10.1179/JOC.2003.15.3.287

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference

PubMed ID

12868557